SELLAS Life Sciences Group, Inc. (SLS) Return on equity 2019–2022
SELLAS Life Sciences Group, Inc. (SLS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-851.4%FY2022 · since FY2019: -316.6% → -851.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -851.4% | -749.7 pp |
| FY2021 | -101.7% | -41.8 pp |
| FY2020 | -59.9% | +256.7 pp |
| FY2019 | -316.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice